Validation of the encephalitis criteria in adults with a suspected central nervous system infection: An updated score - 17/09/24
I-PACE study group2

Summary |
Objectives |
We aimed to validate and refine the encephalitis criteria proposed by the International Encephalitis Consortium in a cohort of adults initially suspected of a central nervous system (CNS) infection.
Methods |
We included patients from two prospective cohort studies consisting of adults suspected of a CNS infection whom underwent a diagnostic lumbar puncture. We evaluated the test characteristics of the criteria for both possible and probable encephalitis. The reference standard was a final clinical diagnosis of encephalitis. Recalibration of the criteria was done by adjusting the weight of each criterion based on their respective odds.
Results |
In total 1446 episodes were evaluated, of whom 162 (11%) had a clinical diagnosis of encephalitis. Possible encephalitis had a sensitivity of 41% (95% CI 33–49) and a specificity of 88% (95% CI 86–90). Probable encephalitis had a sensitivity and specificity of respectively 27% (95% CI 20–34) and 95% (95% CI 94–96). Through odds-based weighting, we recalibrated the weight of each individual criterion, resulting in a model consisting of an altered mental status (weight of 2), seizures (weight of 3), elevated CSF leukocytes (weight of 5) and abnormalities on neuroimaging (weight of 9). We proposed a cut-off at 5 for possible encephalitis, (sensitivity 93% [95% CI 88–96]; specificity 51% [95% 49–54]), and at 8 for probable encephalitis (sensitivity 51% [95% CI 44–59]; specificity 91% [95% CI 89–92]).
Conclusions |
We validated and refined the existing diagnostic criteria for encephalitis, leading to a substantially enhanced sensitivity. These updated criteria hold promise to facilitate the accurate identification of encephalitis.
Le texte complet de cet article est disponible en PDF.Keywords : Encephalitis, Diagnostic prediction model, Validation
Plan
Vol 89 - N° 4
Article 106239- octobre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?